Neil Gregory Almstead, CHIEF TECHNICAL Operations OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 2,464 shares at $90.25 ($222K) on 2026-07-09, disclosed to the SEC on 2026-07-13.
Scheduled sale ($222k) by CHIEF TECHNICAL Operations OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PTCT | SELL | 2026-06-26 | $2.3M | — | Filing → |
| PTCT | SELL | 2026-06-24 | $1.9M | — | Filing → |
| PTCT | SELL | 2026-04-03 | $3.6M | — | Filing → |